@entity5967 ( @entity5011 ) is a leading cause of serious @entity281 . In this study we determine the prevalence, serotype distribution and genomic diversity of @entity5011 in vagina of pregnant @entity1 . Vaginal swabs of 531 pregnant @entity1 were cultured on Columbia Agar Base Blood, @entity5011 Agar Base and Todd Hewitt Broth. @entity5011 were characterized by group and type-specific agglutination. Genomic polymorphism was studied by random amplification of DNA (RAPD). Seventeen @entity1 (3.2%) were positive for @entity5011 , resulting serotype III the most frequent. RAPD detected 16 different RAPD profiles from 21 @entity5011 studied, revealing a good discriminatory power. In this sense, this method showed different genotype from @entity5011 serotype III recovered from successive samples of two @entity1 , suggesting reinfection. In conclusion, the combination of RAPD and serotyping appear promising for epidemiological studies. Finally, findings of reinfection after therapy during pregnancy, led us to suggest performing prenatal @entity5011 screening and intrapartum prophylaxis in order to reduce neonatal risk.

Phenotypic and genotypic study of @entity5967 in vagina of pregnant XXXX in Argentina.

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity281 :: ('MESH:D007239', 'Disease') :: ['neonatal infection'] @entity5011 :: ('MESH:D020275', 'Disease') :: ['GBS'] @entity5967 :: ('1311', 'Species') :: ['Streptococcus agalactiae']
@entity1 :: (9606,Species) :: ['women']
